Delivery Order 36E79724D0005-15B41224F00000058
Award Date
9/15/24
Potential Completion Date
10/15/24
Potential Value
$2.4K
Federal Agency
Federal Medical Center Rochester
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Glaxosmithkline, LLC has been awarded a firm fixed price delivery order against the Department of Justice Bureau of Prisons for $4,407.75 to supply influenza virus vaccine for the 2024-2025 flu season. The contract number is 36E79724D0005 and performance will occur at Glaxosmithkline's Durham, North Carolina facility with completion by September 30, 2024. No set-aside designation was used for this award to support the Bureau of Prisons' inmate healthcare services at the Federal Correctional...
This is a delivery order awarded by the Department of Justice Bureau of Prisons Central Office to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of the influenza vaccine Fluarix pre-filled syringe. The contract has a potential value of $2,742.60 and is a firm fixed price contract with no set-aside designation. The contract performance will take place at Glaxosmithkline's facilities in Durham, North Carolina, and the period of performance ends on October 15, 2024....
This is a $3,918 firm fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Institution Schuylkill to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other products to U.S. government agencies. The contract is for the delivery of B1 FY24 influenza vaccines to inmates and staff at the Durham, North Carolina correctional facility. This award is not associated with a...
This is a firm fixed price delivery order awarded by the Department of Justice Bureau of Prisons Federal Correctional Complex Petersburg to GlaxoSmithKline, LLC for the provision of FY24 M4 flu vaccines. The contract has a potential value of $1,959.00 and a completion date of May 30, 2024. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has provided a range of pharmaceutical goods and services to various U.S. government agencies through federal contracts and grants. This...
Glaxosmithkline, LLC (GSK) has been awarded a firm fixed price delivery order against an existing contract vehicle to provide influenza virus vaccines for the Federal Medical Center in Devens, Massachusetts. Valued at $6,366.75, the contract calls for GSK to deliver 50% of the ordered vaccines between August 15 and September 15, 2024, with the remaining 50% due by October 15, 2024. The award was issued by the Department of Justice's Bureau of Prisons to support immunization of staff and...
Glaxosmithkline, LLC has been awarded a $58,770 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to provide FLUARIX influenza virus vaccines. Performance will occur at Glaxosmithkline's Durham, North Carolina facility through October 15, 2024. Glaxosmithkline holds several indefinite delivery contracts with federal agencies to supply seasonal influenza vaccines and other pharmaceutical products,...
The Department of the Army awarded a $34,586.40 firm fixed price delivery order to Glaxosmithkline, LLC for FLUARIX QUADRIVALENT FLU VACCINE. As the prime contractor, Glaxosmithkline will deliver the influenza vaccine to support the Department of the Army's public health and readiness programs. The contract has a period of performance through September 14, 2022 and was awarded on August 17, 2022 without a set-aside designation. The place of performance will be Glaxosmithkline's facility in...
This is a firm fixed-price delivery order contract awarded by the United States Penitentiary McCreary, part of the U.S. Department of Justice, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the purchase of Fluarix pre-filled syringes for the 2024-2025 flu season, with a ceiling value of $5,877.00 and a period of performance through April 22, 2025. The contract is not set aside for any specific business type. Glaxosmithkline is a global...
This is a firm fixed price delivery order contract awarded by the Department of Justice Bureau of Prisons Federal Prison Camp Alderson to GlaxoSmithKline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, valued at $3,918.00, is for the delivery of Fluarix pre-filled syringes for the 2024-2025 flu season. This order is not associated with any set-aside designation. GlaxoSmithKline has a...
Glaxosmithkline, LLC has been awarded an $11,754 firm fixed price delivery order by the Department of Justice Bureau of Prisons United States Penitentiary Hazleton to provide 2024-2025 influenza vaccines as part of the facility's pharmaceutical prime vendor contract. No set-aside was designated for this order, which will support the correctional facility's influenza prevention efforts through delivery of vaccines by October 15, 2024. As a major supplier of pharmaceuticals to U.S. government...